Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu

Juniorprof. Dr. Matthias Leisegang

Charité - Universitätsmedizin Berlin

You are here:


Tumor Immunology, T Cell Engineering

  • Preclinical cancer models to analyze the efficacy of TCR gene therapies.
  • Engineering of T cell specificity - vector design, modification of TCR chains.
  • Evaluation of antigens as targets of TCR-modified T cells

Additional information

Professor Dr. rer. nat. Matthias Leisegang is Junior Professor for Adoptive T Cell Therapy at the Institute of Immunology, Charité - Universitätsmedizin Berlin.